About PAM      PAM members       Consumers / Patient 

Home | Message BoardRegister | Search | Email us

Pharmaceutical Association of Mauritius

 

 Industry Headlines, Health News, BBC Health News, Research News,

 Industry Headlines


Feb-March 2002             Dec 2002 - Jan 2003    Feb-March 2003    April-May 2003


2/7 Valtrex, Imitrex Patent Challenge Speculation
Glaxo hit by fears for Valtrex, Imigran patents...Imitrex could be vulnerable from December 2006, when another patent related to the drug class expires...patent on the antiviral Valtrex runs until June 2009... Imitrex's composition of matter patent expires in August 2008…[ Reuters/Yahoo]


2/7 Iressa
Japanese death toll rises from anticancer drug...newly reported deaths has been on the decline since late December, when the government tightened its prescription guidelines…[ AP/Yahoo]
AstraZeneca drug linked to 173 Japanese deaths...decision to start a new clinical trial in Japan was unlikely to affect the U.S. Food and Drug Administration's assessment …[ Reuters/Yahoo]


2/7 Dr Reddy Glitizone: Win Some, Lose Some
Dr. Reddy's: Novo Nordisk To Develop Balaglitazone Drug...suspended phase 3 clinical trials of Ragaglitazar after it found tumors in one mouse and several rats in long-term ...decision to develop Balaglitazone as a substitute for dropping Ragaglitazar…[ Dow Jones/Yahoo]
See Also> Similar Report From Reuters/Yahoo
See Also> Dr Reddy's Press Release

2/7 BI Announces Tipranavir Phase III
Boehringer Ingelheim Launches Global Phase III Clinical Trials For New Anti-HIV Agent Tipranavir...first non-peptidic protease inhibitor (NPPI) in development ...Largest Ever for HIV-Positive Patients Previously Treated with Three Classes of Antiretrovirals …[ Boehringer Ingelheim GmbH Press Release]


2/7 Rep Visits Linked To Early Adopter Behavior
UK Docs Who See Drug Reps Often May Prescribe More...when a new drug became available, they were more likely than other physicians to first try the drug …[ Reuters/Yahoo]


2/7 PFE/PHA MegaMerger; Euro-Regulators Decision Out Soon
EU regulators to decide on Pfizer-Pharmacia merger by end of February...antitrust watchdog said Thursday it would decide by the end of February whether to clear or extend the review of…[ AP/Yahoo]


2/7 Merck Pulls Experimental Anxiety Drug
Merck drops development of experimental anxiety drug...known as Gaba Alpha 2/Alpha 3, was in mid-stage clinical trials …[ Reuters/Yahoo]